![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Resistance Associated Variants: Data From the NIAID SYNERGY Trial
/ Harvoni-Retreating Short Duration Therapy
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Eleanor M. Wilson1; Sarah Kattakuzhy2; Hongmei Mo3; Anuoluwapo Osinusi3; Henry Masur4; Anita Kohli5; Shyam Kottilil6
1Inst of Human Virology, Baltimore, MD, USA; 2Inst of Human Virology, Bethesda, MD, USA; 3Gilead Scis, Inc, Foster City, CA, USA; 4NIH, Bethesda,
MD, USA; 5Dignity Hlth, St. Joseph’s Hosp, Phoenix, AZ, USA; 6Univ of Maryland Med Cntr, Baltimore, MD, USA
![CROI1](../images/030716/030716-2/CROI1.gif)
![CROI2](../images/030716/030716-2/CROI2.gif)
![CROI3](../images/030716/030716-2/CROI3.gif)
![CROI4](../images/030716/030716-2/CROI4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|